Bladder cancer: colour-blind people have lower survival rate
Early symptoms can go unnoticed by people who have difficulty with colour vision. People with bladder cancer who are colour-blind had a 52% higher risk of dying after diagnosis, a study says.
Colour-blind people may have lower survival rates from bladder cancer
People with bladder cancer who are colour-blind were 52% more likely to die within 20 years of diagnosis.
Cape Verdean women researchers investigate cancer diagnosis and antibiotic use with support from the Gulbenkian Foundation
Two Cape Verdean researchers aim to strengthen the diagnosis of blood cancer and the “rational use” of antibiotics in Cape Verde through projects funded by the Calouste Gulbenkian Foundation, with the goal of improving healthcare in the country.
Study reinforces suspicion that the Epstein–Barr virus may cause multiple sclerosis
🩺 Health#medical-research+3 more
It is known that everyone who develops multiple sclerosis has previously had infectious mononucleosis, or the “kissing disease”.
Study strengthens suspicion that Epstein–Barr virus may cause multiple sclerosis
A new study from the Karolinska Institute strengthens evidence that Epstein–Barr virus (EBV), the common cause of glandular fever, can trigger an immune response that damages the brain and may contribute to the development of multiple sclerosis (MS). The research supports the hypothesis that EBV infection is a key environmental driver of MS, a chronic inflammatory neurological disease affecting nearly three million people worldwide, in which the immune system attacks the central nervous system.
Cientistas desenvolvem teste para prever doença de Crohn
A discovery by a Canadian institute enables early diagnosis through blood tests that measure antibody immune responses. The study aims to develop a preventive vaccine.
British research says it has found a solution to female infertility
A scientific discovery in in vitro fertilisation and assisted reproduction could change the paradigm of infertility. The development was announced today by a group of British researchers who say they are working on a protein that prevents the chromosomes in women's eggs from separating during the early stages of pregnancy.
Portuguese therapy promises to treat aggressive cancers
The discovery of the molecule LUZ51 is a promising step for photodynamic therapy as a potential solution to fight cancer. Observador spoke to researcher Luís Arnaut.
Photodynamic molecule used as a weapon against cancer
A group of scientists in Coimbra has developed a new molecule for treating cancer. The clinical treatment involves photodynamic molecules that will act inside cancer cells.
What if it were possible to put cancer cells to sleep?
At the Champalimaud Foundation in Lisbon, scientist Ana Luísa Correia is researching an innovative way to prevent the formation of breast cancer metastases.
Science: 'New molecule clearly much more potent'
Luís Arnaut, a professor at FCTUC (Faculty of Science and Technology, University of Coimbra), explains more about a molecule developed by a group of researchers at the University of Coimbra that makes the process of combating cancer cells more effective.
Portugal scientists develop innovative molecule for cancer treatment
Home News Portugal scientists develop innovative molecule for cancer treatment Portugal scientists develop innovative molecule for cancer treatment A group of researchers from the University of Coimbra has developed an innovative molecule that could represent a significant advance in the treatmen
Diagnosing strokes more quickly and more accurately
If all goes well, in ten years' time we will have better stroke diagnoses. Victoria Leiro's work will enable faster interventions, fewer long-term disabilities and more lives saved.
The particle count that could change the fight against cancer
At the Laboratory of Instrumentation and Experimental Particle Physics in Lisbon, Pedro Assis’s team is developing a system capable of delivering radiotherapy more effectively.
A moonshot for animal-free European health research
With 95 percent of drugs failing clinical trials, it’s clear that a new approach is needed. Let’s not miss this chance to invest in a new kind of science.
Portuguese scientists seek to treat atopic dermatitis with a skin bacterium
A European consortium aims to transform a bacterium associated with acne into a diagnostic and treatment vehicle for atopic dermatitis. A team from the Faculty of Sciences of Lisbon is part of the research.
Treatment for Spinal Cord Injury Discovered
Recovery demonstrated by several patients opens the possibility for the treatment to be applied on a large scale, once clinical trials with a larger number of people are completed.
